The growing challenge of party drugs in general practice

Australian Family Physician

Volumn 33, Issue 9, 2004, Pages 709-713

  Khong, Eric ^a   Wain, Toni ^b  

^a EDITH COWAN UNIVERSITY   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL DEPRESSANT AGENT; CENTRAL STIMULANT AGENT; PSYCHEDELIC AGENT; STREET DRUG;

ADDICTION; ADOLESCENT; ADULT; AGE DISTRIBUTION; AUSTRALIA; GENERAL PRACTICE; HEALTH BEHAVIOR; HUMAN; LEISURE; METHODOLOGY; PATIENT EDUCATION; PREVALENCE; REVIEW;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AUSTRALIA; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CENTRAL NERVOUS SYSTEM STIMULANTS; FAMILY PRACTICE; HALLUCINOGENS; HEALTH BEHAVIOR; HUMANS; LEISURE ACTIVITIES; PATIENT EDUCATION; PREVALENCE; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 16544380268     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lenton S, Boys A, Norcross K. Raves, drugs and experience: a study of drug use among a sample of people who attend raves in Western Australia. Addiction 1997;92:1327-1337.
2. Jones-Webb R. Relationships among alcohol availability, drinking location, alcohol consumption and drinking problems in adolescents. Subst Use Misuse 1998;32:1261-1285.
3. National Drug Strategy Household Survey. Canberra: AIHW, 2001.
4. Zinberg NE. Drug, set and setting: the basis for controlled intoxicant use. Yale University Press, 1984.
5. Degenhardt L, Topp L. 'Crystal meth' use among polydrug users in Sydney's dance party subculture: characteristics, use patterns and associated harms. International Journal of Drug Policy 2003;14:17-24.
6. Solowij N, Hall W, Lee N. Recreational MDMA use in Sydney: a profile of 'ecstasy' users and their experiences with the drug. Br J Addiction 1992;87:1161-1172.
7. Topp L, Breen C, Kaye S, Darke S. NSW party drug trends 2001. Findings from the Illicit Drug Reporting System (IDRS). Technical Report Number 136. Sydney: National Drug and Alcohol Research Centre,.
8. Byard RW, Rodgers NG, James RA, et al. Death and paramethoxyamphetamine: an evolving problem. Med J Aust 2002;176:496.
9. White JM, Bochner F, Irvine R. The agony of 'ecstasy'. Med J Aust 1997;166:117.
10. Cole JC, Bailey M, Sumnall HR, Wagstaff GF, King LA. The content of ecstasy tablets: implications for the study of their long term effects. Addiction 2002;97:1531-1536.
11. Party Drugs Trends Bulletin. National Drug and Alcohol Research Centre, June 2004.
12. Party Drugs Trends Bulletin. National Drug and Alcohol Research Centre, December 2003.
13. Drugs Trends Bulletin. National Drug and Alcohol Research Centre, April 2001.
14. Boys A, Marsden J, Griffiths P, Fountain J, Stillwell G, Strang J. Substance use among young people: the relationship between perceived functions and intentions. Addiction 1999;94:1043-1050.
15. Baxter T, Bacon P, Housman M, van Beek I. Targeting psychostimulant drug users: the rave safe project. In: Godding R, Whelan G, eds. Proceedings of the 1994 autumn school of studies on alcohol and drugs. Melbourne: Department of Drug and Alcohol Studies, St. Vincent's Hospital, 1994;49-52.
16. Kang M. An approach to adolescent drug use. Aust Fam Physician 2002;31:14-17.
17. Levine RJ. Adolescents as research subjects without permission of their parents or guardians: ethical considerations. J Adolesc Health 1995;17:287-297.
18. Gillick v West Norfolk and Wisbech Area Health Authority (1986) AC 112.
19. Swift W, Copeland J, Lenton S. Cannabis and harm reduction. Drug and Alcohol Review 2000;19:101-112.
20. Baker A, Kay-Lambkin F, Lee NK, et al. A brief cognitive behavioural intervention for regular amphetamine users. Canberra: Australian Government Department of Health and Ageing, 2003.